Vascular occlusion device and delivery assembly

By using joints formed by tight end bundles and tensile-resistant members in the vascular occlusion device, the problem of easy disintegration of electrolytic separable joints in the prior art is solved, the tensile strength and shape retention of the device are improved, and the Stability in aneurysms.

CN118922136APending Publication Date: 2024-11-08STRYKER CORP +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380021270.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-02-11
Filing Date
2023-02-08
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

During the release of existing vascular occlusion devices into an aneurysm, electrolytic separable joints are susceptible to electrolysis, resulting in performance limitations, including problems of fracture performance, shape retention and insufficient flexibility.

Method used

Using a blood vessel occlusion device that is detachably coupled through the conveying assembly joint, the tight end bundle and the tensile-resistant member form the inner joint and the conveying joint, and the bend of the tensile-resistant member is formed by adhesive or welding to ensure the joint. Strength and stability.

Benefits of technology

It improves the tensile strength and shape retention of the vascular occlusion device, reduces the risk of electrolytic degradation, and enhances stability and adaptability in the blood vessels.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118922136A_ABST
    Figure CN118922136A_ABST
Patent Text Reader

Abstract

A vascular occlusion treatment system includes a delivery assembly and a vascular occlusion device removably coupled to the delivery assembly through a delivery assembly joint. The vascular occlusion device includes a braided portion formed of one or more threads, the braided portion including a tamped end bundle. The vascular occlusion device also includes a coiled portion coupled to the woven portion. The vascular occlusion device also includes an in-device joint coupling the braided portion to the coiled portion, the in-device joint including a tensile member spanning from the tamped end bundle to the delivery assembly joint.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] Citations of Related Applications

[0002] This application claims the benefit of U.S. Provisional Patent Application No. 63 / 309,300, filed on February 11, 2022, the entire disclosure of which is expressly incorporated herein by reference. Technical Field

[0003] The field of the present disclosure generally relates to vascular occlusive devices for establishing embolism or vascular occlusion in a blood vessel of a human patient. More specifically, the present disclosure relates to at least partially braided or woven vascular occlusive devices, connectors within such devices, and connectors for coupling such devices to treatment systems. Background Art

[0004] Vascular occlusive devices or implants are used for a variety of purposes including the treatment of intravascular aneurysms. Commonly used vascular occlusive devices include soft, helically wound coils formed by winding a platinum (or platinum alloy) wire around a "primary" mandrel. The coil is then wound around a larger "secondary" mandrel and heat treated to impart a secondary shape. For example, U.S. Pat. No. 4,994,069 to Ritchart et al., which is incorporated herein by reference in its entirety as set forth in its entirety, describes a vascular occlusive device that exhibits a linear, helical primary shape when stretched to pass through the lumen of a delivery catheter and exhibits a folded, helical secondary shape when released from the delivery catheter and deposited in the vascular system. Other examples of vascular occlusive devices include at least partially braided or woven devices, such as devices described in U.S. Pat. No. 10,321,915 to Murphy et al. and U.S. Pat. No. 10,893,870 to Wang et al., which are incorporated herein by reference in their entirety as set forth in their entirety.

[0005] In order to deliver the vascular occlusive device to the desired position in the vascular system, such as within the aneurysm sac, it is well known that a low-profile delivery catheter or "microcatheter" is first positioned at the position using a steerable guidewire. Typically, the distal end of the microcatheter is provided by the attending physician or by the manufacturer with a selected preformed bend, such as 45°, 90°, "J", "S" or other curved shapes, depending on the patient's specific anatomical structure, so that once the guidewire is pulled out, it will remain in the desired position for releasing one or more vascular occlusive devices into the aneurysm. Then, the delivery or "pusher" assembly or "wire" passes through the microcatheter until the vascular occlusive device pushed by the distal end of the delivery assembly extends out of the distal opening of the microcatheter and extends into the aneurysm. Once in the aneurysm, the various parts of the vascular occlusive device are deformed or bent to allow for more effective and complete packing. The vascular occlusive device connected to the distal end of the delivery assembly is released or "detached" from the distal end of the delivery assembly after extending into the aneurysm. Then, the delivery assembly is pulled back through the catheter. Depending on the patient's specific needs, one or more additional vaso-occlusive devices may be advanced through the catheter and released at the same location.

[0006] A well-known method of releasing a vaso-occlusive device from the end of a delivery assembly is to use an electrolytically detachable connector, which is a small exposed portion or breakaway zone located along the distal portion of the delivery assembly. The breakaway zone is typically made of stainless steel and is located just proximal to the vaso-occlusive device. The electrolytically detachable connector is susceptible to electrolysis and disintegrates when the delivery assembly is charged in the presence of an ionic solution such as blood or other body fluids. Thus, once the breakaway zone leaves the distal end of the catheter and is exposed to the patient's vascular blood pool, the current applied to the conductive pusher through electrical contact with the return electrode completes the electrolytic breakaway circuit and the breakaway zone disintegrates due to electrolysis. Other breakaway mechanisms for releasing a vaso-occlusive device from a delivery assembly include mechanical, thermal, and hydraulic mechanisms.

[0007] To better frame and fill aneurysms, complex three-dimensional secondary shapes can be imparted on vascular occlusive devices, and the stiffness / flexibility of vascular occlusive devices can be modified. However, vascular occlusive devices still have performance limitations, including fracture performance, shape retention, and flexibility.

[0008] The proximal end of some vaso-occlusive devices is coupled to the distal end of a delivery assembly, which is known as the "main connector" or "delivery assembly connector" or simply "delivery connector" of a vaso-occlusive treatment system. Another main connector design is disclosed in U.S. Pat. No. 8,202,292 to Kellett, which is incorporated herein by reference as set forth in its entirety. The main connector includes a flat adapter that couples a delivery wire to the vaso-occlusive device. The delivery wire has a hook-shaped or "J"-shaped distal end that is configured to be received in a hole in the proximal end of the adapter to couple the delivery wire to the adapter. The vaso-occlusive device has a winding that defines an opening that is configured to receive a finger at the distal end of the adapter to couple the vaso-occlusive device to the adapter. Thus, the adapter facilitates coupling the delivery wire to the vaso-occlusive device. Other main connector designs are disclosed in U.S. Pat. No. 9,480,479 to Chen et al., which is incorporated herein by reference as set forth in its entirety.

[0009] Some vascular occlusive devices include one or more braided portions and one or more coiled portions. In such vascular occlusive devices, the braided portion and the coiled portion are connected by one or more "device internal joints". Some vascular occlusive devices also include a stretch-resistant member that is configured to keep the coiled portion compacted or compressed to control the structural properties (e.g., flexibility and stiffness) of the coiled portion, which can change when the coiled portion is stretched. The stretch-resistant member can form part of both the device internal joint and the delivery joint. In some vascular occlusive devices, the stretch-resistant member is formed by one or more braided wires that pass through the first end of the coiled portion and are fixed at its second end. In such vascular occlusive devices, the diameter of the stretch-resistant member depends on the diameter of the braided wires that form the braided portion. Therefore, the structural properties of the device internal joint and the delivery joint do not necessarily depend on the properties of the braided wire. Therefore, a vascular occlusive device having a braided portion with a thin braided wire (e.g., a diameter of 0.0008 inches or 0.0009 inches) will have a device internal joint and a delivery joint with a lower tensile strength.

[0010] Therefore, there remains a need for a vaso-occlusive treatment system having a vaso-occlusive device and methods of making the same, wherein the size of the braided portion is independent of the strength of the connector and delivery connector within the device. Summary of the invention

[0011] According to one aspect of the present disclosure, a vascular occlusion treatment system includes a delivery assembly and a vascular occlusion device detachably coupled to the delivery assembly via a delivery assembly connector. The vascular occlusion device includes a braided portion formed of one or more wires, the braided portion including a constricted end bundle. The vascular occlusion device also includes a coiled portion coupled to the braided portion. The vascular occlusion device also includes an in-device connector coupling the braided portion to the coiled portion, the in-device connector including a stretch-resistant member spanning from the constricted end bundle to the delivery assembly connector.

[0012] According to various aspects of the present disclosure, the constricted end bundle includes an adhesive disposed at an end of the braided portion or a weld disposed at an end of the braided portion. The constricted end bundle may define an end surface that is orthogonal or inclined relative to a longitudinal axis of the constricted end bundle.

[0013] According to various aspects of the present disclosure, the stretch-resistant member includes a first end and a second end. The first end of the stretch-resistant member can terminate in the transmission line connector, and the second end of the stretch-resistant member can terminate in the braided portion or the coiled portion. The first end and the second end can be flattened. The first end and the second end can each terminate in the braided portion. The first end and the second end can cross each other in the braided portion.

[0014] According to various aspects of the present disclosure, the stretch-resistant member includes a bend. The first end and the second end may terminate within the transmission line connector, and the bend may be disposed near the constricted end bundle. The bend may be disposed at the distal end of the constricted end bundle. The first end and the second end may terminate near the constricted end bundle, and the bend may be disposed within the transmission line connector. The transmission assembly connector may include a link defining an opening, and the bend may be disposed in the opening. Each of the first end and the second end may terminate within the braided portion.

[0015] According to various aspects of the present disclosure, the vascular occlusion treatment system further comprises a second stretch-resistant member, the second stretch-resistant member comprising a third end and a fourth end. The first end and the third end may terminate in the delivery line connector, and the second end and the fourth end may terminate near the constricted end bundle.

[0016] According to various aspects of the present disclosure, the stretch-resistant member is a ring including a first bend and a second bend. The first bend can be disposed within the delivery line connector, and the second bend can be disposed near the constricted end bundle. The first bend can be disposed at the distal end of the constricted end bundle. The delivery assembly connector can include a link defining an opening, and the second bend can be disposed in the opening.

[0017] According to various aspects of the present disclosure, the constricted end bundle is a proximal end bundle, the coiled portion is a proximal coiled portion, the in-device joint is a proximal in-device joint, the stretch-resistant member is a proximal stretch-resistant member, and the braided portion further comprises a distal constricted end bundle. The system further comprises a distal coiled portion coupled to the distal constricted end bundle and a distal in-device joint coupling the braided portion to the distal coiled portion. The distal in-device joint comprises a distal stretch-resistant member spanning from the distal constricted end bundle to the distal end of the distal coiled portion.

[0018] According to various aspects of the present disclosure, the distal constricted end bundle includes an adhesive disposed at the distal end of the braided portion or a weld disposed at the distal end of the braided portion. The distal constricted end bundle may define a distal end surface that is orthogonal or inclined relative to a longitudinal axis of the distal constricted end bundle.

[0019] According to various aspects of the present disclosure, the distal anti-stretch member includes a first distal anti-stretch member end and a second distal anti-stretch member end. The first distal anti-stretch member end of the distal anti-stretch member may terminate in the distal end of the distal coiled portion, and the second distal anti-stretch member end of the distal anti-stretch member may terminate in the braided portion or the distal coiled portion. The first distal anti-stretch member end and the second distal anti-stretch member end may be flat. The first distal anti-stretch member end and the second distal anti-stretch member end may each terminate in the braided portion. The first distal anti-stretch member end and the second distal anti-stretch member end may cross each other in the braided portion.

[0020] According to various aspects of the present disclosure, the distal stretch-resistant member includes the distal stretch-resistant member bend. The first distal stretch-resistant member end and the second distal stretch-resistant member end may terminate in the distal end of the distal coiled portion, and the distal stretch-resistant member bend may be disposed near the distal constricted end bundle. The distal stretch-resistant member bend may be disposed at the proximal end of the distal constricted end bundle. The first distal stretch-resistant member end and the second distal stretch-resistant member end may terminate near the distal constricted end bundle, and the distal stretch-resistant member bend may be disposed in the distal end of the distal coiled portion. Each of the first distal stretch-resistant member end and the second distal stretch-resistant member end may terminate in the braided portion.

[0021] According to various aspects of the present disclosure, the vascular occlusion treatment system further comprises a second distal anti-stretch member, the second distal anti-stretch member comprising a third distal anti-stretch member end and a fourth distal anti-stretch member end. The first distal anti-stretch member end and the third distal anti-stretch member end may terminate within the distal end of the distal coiled portion, and the second distal anti-stretch member end and the fourth distal anti-stretch member end may terminate near the distal constricted end bundle.

[0022] According to various aspects of the present disclosure, the distal stretch-resistant member is a ring including a first distal stretch-resistant member bend and a second distal stretch-resistant member bend. The first distal stretch-resistant member bend may be disposed within the distal end of the distal coiled portion, and the second distal stretch-resistant member bend may be disposed near the distal constricted end bundle. The first distal stretch-resistant member bend may be disposed at the proximal end of the distal constricted end bundle.

[0023] According to various aspects of the present disclosure, the delivery assembly has a distal end, wherein the distal end forms a hook. The delivery assembly connector may include a link having a proximal end and a distal end, wherein the distal end of the link includes a plurality of fingers.

[0024] According to another aspect of the present disclosure, a method of manufacturing a vascular occlusion treatment system includes: forming a vascular occlusion device. Forming the vascular occlusion device includes: placing a tube around a proximal end of a braided portion formed of one or more wires, applying heat to the tube to shrink the tube around the proximal end of the braided portion to form a shrunken proximal end, applying glue to the shrunken proximal end to form a constricted end bundle, removing the tube from around the constricted end bundle, passing a stretch-resistant member through the braided portion adjacent to the distal end of the constricted end bundle to form a bend of the stretch-resistant member in the braided portion adjacent to the distal end of the constricted end bundle, inserting at least a portion of the constricted end bundle and the stretch-resistant member into a coiled portion, and applying glue to the constricted end bundle and the bend of the stretch-resistant member to form an intra-device joint. The method also includes: connecting the distal end of a delivery assembly to the proximal end of the coiled portion and the proximal end of the stretch-resistant member. The method further includes applying glue to the distal end of the delivery assembly, the proximal end of the coiled portion, and the proximal end of the stretch-resistant member to form a delivery joint.

[0025] According to another aspect of the present disclosure, a method for manufacturing a vascular occlusion treatment system includes forming a constricted end bundle. Forming the constricted end bundle includes: arranging a tube around a proximal end of a braided portion formed by one or more wires, applying heat to the tube to shrink the tube around the proximal end of the braided portion to form a shrunk proximal end, applying glue to the shrunk proximal end to form a constricted end bundle, and removing the tube from around the constricted end bundle. The method also includes: forming a delivery connector. Forming the delivery connector includes: coupling a distal end of a link to a proximal end of a coiled portion, coupling a distal end of a delivery assembly to a proximal end of the link, passing a stretch-resistant member through an opening defined by the link to form a curved portion of the stretch-resistant member in the opening, applying glue to the link, the proximal end of the coiled portion, the distal end of the delivery assembly, and the curved portion of the stretch-resistant member to form the delivery connector. The method also includes: inserting at least a portion of the constricted end bundle into the coiled portion. Additionally, the method includes coupling an end of the stretch resistant member to the braided portion adjacent the distal end of the constricted end bundle. Additionally, the method includes applying glue to the constricted end bundle and the end of the stretch resistant member to form an intra-device joint.

[0026] According to various aspects of the present disclosure, the coiled portion is a proximal coiled portion, and the method further includes coupling a distal coiled portion to a distal end of the braided portion.

[0027] Other and further aspects and features of the present disclosure will become apparent from the following detailed description taken in conjunction with the accompanying drawings. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] This patent or application file contains at least one drawing printed in color. The United States Patent and Trademark Office will provide copies of this patent or patent application publication with color drawing(s) upon request and payment of the necessary fee.

[0029] The accompanying drawings illustrate the design and practicality of various aspects of the present disclosure, wherein similar elements are represented by common reference numerals. These figures are not necessarily drawn to scale. In order to better understand how to obtain the above and other advantages and purposes, the present disclosure will be described in more detail, which is shown in the accompanying drawings. For the purpose of illustration and convenience of the following detailed description, these figures only depict exemplary aspects of the present disclosure and therefore should not be considered to limit the scope of the present disclosure.

[0030] Figure 1 is a schematic diagram of an exemplary vaso-occlusive treatment system including a vaso-occlusive device and a delivery assembly according to various aspects of the present disclosure.

[0031] Figure 2A and Figure 2B is a detailed schematic diagram depicting steps in making an exemplary vaso-occlusive device according to various aspects of the present disclosure.

[0032] Figures 3 to 7 is a schematic diagram of an exemplary vaso-occlusive treatment system including respective vaso-occlusive devices and delivery assemblies according to various aspects of the present disclosure.

[0033] Figures 8 to 10 is a detailed schematic diagram of an exemplary intra-device connector in a vaso-occlusive device according to various aspects of the present disclosure.

[0034] FIG. 11A to FIG. 11I is a series of schematic diagrams depicting exemplary methods of making a vaso-occlusive treatment system including a vaso-occlusive device and a delivery assembly according to various aspects of the present disclosure.

[0035] FIG. 12A to FIG. 12I is a series of schematic diagrams depicting exemplary methods of making a vaso-occlusive treatment system including a vaso-occlusive device and a delivery assembly according to various aspects of the present disclosure.

[0036] FIG. 13A to FIG. 13D is a schematic diagram depicting a proximal constricted end bundle of a corresponding vaso-occlusive device according to various aspects of the present disclosure. DETAILED DESCRIPTION

[0037] This specification describes exemplary aspects and applications of the present disclosure. However, the present disclosure is not limited to these exemplary aspects and applications, nor is it limited to the manner in which the exemplary aspects and applications operate or the manner described herein. In addition, the drawings may show simplified or partial diagrams, and the sizes of the elements in the drawings may be exaggerated or disproportionate. In addition, elements of similar structures or functions are represented by the same reference numerals in all drawings. In addition, the aspects shown do not necessarily have all the features or advantages shown. Features or advantages described together with a particular aspect are not necessarily limited to that aspect, and may be practiced in any other aspect even without such description.

[0038] For the following defined terms, these definitions shall apply unless a different definition is given in the claims or elsewhere in this specification.

[0039] When the terms "on," "attached to," "connected to," "coupled to," "fixed to," or similar terms are used herein, an element (e.g., a material, layer, substrate, etc.) may be "on," "attached to," "connected to," "coupled to," or "fixed to" another element, regardless of whether the one element is directly on, attached to, connected to, coupled to, or fixed to the other element, or whether there are one or more intermediate elements between the one element and the other element. If directions are provided (e.g., above, below, top, bottom, side, above, below, under, above, upper, lower, horizontal, vertical, "x," "y," "z," etc.), the directions are relative and are provided by way of example only and for ease of illustration and discussion, and not by way of limitation. When referring to a list of elements (e.g., elements a, b, c), such reference is intended to include any one of the listed elements themselves, any combination of less than all of the listed elements, and / or combinations of all of the listed elements.

[0040] As used herein, "substantially" means sufficient for the intended purpose. Thus, the term "substantially" allows for minor, insignificant variations from an absolute or perfect state, dimension, measurement, result, etc., such as would be expected by one of ordinary skill in the art, but does not significantly affect overall performance. The term "some" means more than one.

[0041] Whether or not explicitly stated, it is assumed herein that all numerical values ​​are modified by the term "about". The term "about" generally refers to a numerical range that is considered by those skilled in the art to be equivalent to the value (i.e., having the same function or result). In many cases, the term "about" can include numbers rounded to the nearest significant figure. Numerical ranges represented by endpoints include all numbers within the range (e.g., 1 to 5 include 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).

[0042] As used in this specification and the appended claims, the singular forms "a", "an", and "the" include plural references unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term "or" is generally used in a sense including "and / or" unless the content clearly dictates otherwise.

[0043] As used herein, a plurality of "elongated members" used to form a braid may include only a single elongated member used to form the braid, i.e., wherein the single elongated member folds back on itself at the end of the braid. As used herein, the terms "tube," "tubular," "diameter," "radius," and "circumference" encompass objects having non-circular cross-sections as well as objects having circular cross-sections. As used herein, the terms "stiffness" or "flexibility" when referring to a wire, coil, braid, or portion thereof include, but are not limited to, bending stiffness. As used herein, the term "constrained" includes, but is not limited to: (1) the braid is maintained in a compressed, elongated configuration due to forces applied thereto, such as forces applied by a delivery catheter; and (2) the anesthetic is maintained in a compressed, shortened configuration due to forces applied thereto, such as forces applied by a stretch-resistant member. As used herein, the term "unconstrained" includes, but is not limited to, the absence of external forces acting on an object, including, but not limited to, a braid and a coil. Although "unconstrained" is synonymous with "deployed" herein with respect to a braid, some patient anatomies may exert forces on a deployed vascular occlusive device that may include a braid.

[0044] Figure 1 A vascular occlusive treatment system 100 is depicted, which includes a vascular occlusive device 110 having a braided portion 120 and proximal and distal coiled portions 130, 140. The proximal end of the vascular occlusive device 110 is removably coupled to a delivery assembly 150 for delivery into a patient. Details regarding delivery wire assemblies and delivery of vascular occlusive treatment systems are described in U.S. Pat. Nos. 8,202,292, 9,480,479, 10,321,915, and 10,893,870, which are previously incorporated herein by reference.

[0045] The braided portion 120 can be braided from any type of elongated member (e.g., "alloy wire", "wire"), as long as the material used to make such an elongated member is biocompatible. For example, the braided portion 120 can be braided from 24 wires, each having a cross-sectional diameter of 0.001 inches. The braid can be a flat braid or a round braid. According to other aspects of the present disclosure, the braided portion 120 can be braided from 16 to 32 wires, each having a cross-sectional diameter of 0.00075 inches to 0.0015 inches. The proximal coiled portion and the distal coiled portion 130, 140 are coils wound from one or more of the same or different alloy wires. According to other aspects of the present disclosure, portion 120 can be braided from more than 32 wires, each having a cross-sectional diameter of 0.0.00075 inches to 0.0.00125 inches.

[0046] According to some aspects of the present disclosure, the alloy wire or wire can be a drawn filled tube (DFT) provided by Fort Wayne Metals of Fort Wayne, Indiana. The DFT wire includes a substantially pure platinum ("Pt") core at least partially surrounded by a substantially pure nitinol ("NiTi") outer layer. As used in this application, "substantially pure" Pt includes, but is not limited to, 99.95% commercial purity produced in accordance with ASTM B561. The Pt core accounts for approximately 40%-50% of the volume of the DFT wire ("Pt core content"). According to other aspects of the present disclosure, the DFT wire is formed by inserting a core component (solid elongated member) into an outer component (tubular elongated member) to form a composite elongated member (e.g., a composite wire). The composite elongated member is repeatedly mechanically drawn and annealed by heating to increase its axial length and reduce its cross-sectional diameter. For example, the drawing and annealing process may successively reduce the diameter of the composite elongate member from 1 inch to 0.5 inches, from 0.5 inches to 0.25 inches, from 0.25 inches to 0.025 inches, and from 0.025 inches to 0.0025 inches.

[0047] Although the materials (e.g., Pt and NiTi) that form various parts of the DFT wire (e.g., core and outer layer) may have different stiffnesses (i.e., bending stiffness), the relative stiffness (i.e., bending stiffness) of the final part of the DFT may not necessarily reflect the stiffness of the materials from which it is made. For example, even if the bending modulus (i.e., stiffness) of Pt is greater than the bending modulus of NiTi, the bending modulus of Pt combined with the diameter of the Pt wire may make the platinum wire softer (i.e., less stiff) than the corresponding NiTi outer layer.

[0048] The braided portion 120 of the vascular occlusive device 110 can be braided on a mandrel, which can be flat or round, depending on the desired final shape. After braiding, the braided portion 120 can be heat-set (e.g., heated at 500° C. to 550° C. for 1 to 10 minutes). The heat-set braid forms a linear "primary shape" of the braided portion 120. The heat-set braid can then be wrapped around a second mandrel (e.g., a three-dimensional mandrel) and heat-set a second time to impart a three-dimensional "secondary shape." The NiTi outer layer improves the retention of the secondary shape.

[0049] While vascular implants (i.e., stents) have been made from NiTi-DFT-Pt wires having Pt core contents up to about 30%, NiTi-DFT-Pt wires having Pt core contents of about 40% to 50% have not been used to form stents. This is because stents typically require wires having a higher yield strength to ultimate strength ratio (i.e., >80% ultimate tensile strength ("UTS")) to maintain vascular patency. On the other hand, the vascular occlusive device 110 includes a DFT wire having a lower yield strength to UTS ratio, which improves device properties, including lower bending moments and improved fracture performance. According to various aspects of the present disclosure, the DFT wire forming (portions of) the vascular occlusive device 110 has a yield strength to UTS ratio of <50% UTS, <60% UTS, <70% UTS, and <80% UTS. The yield strength is the maximum amount of force that can be applied to a material before the material begins to plastically deform. The UTS is the minimum amount of force that must be applied to a material before the material fails. Braiding at least a portion of the vascular occlusive device from wires having a yield strength to UTS ratio of less than 80% of the UTS is critical to simultaneously achieving the properties of improved radiopacity, shape retention, and fracture performance.

[0050] According to other aspects of the present disclosure, vascular implants including vascular occlusive devices are formed from NiTi-DFT-Pt wires having a Pt core content of about 40% to 50%. Braiding a braided portion 120 with a DFT wire having a Pt core content of about 40% to 50% ("NiTi-DFT-40 / 50Pt") provides a braided portion 120 having (1) radiopacity throughout its length, (2) improved shape retention, and (3) improved fracture performance along the entire braided length. The Pt core provides radiopacity to a majority of the vascular occlusive device 110, thereby providing radiopacity for a variety of vascular occlusive devices implanted in a patient's body. The superelastic properties of the NiTi outer layer help improve shape retention. The flexibility of Pt helps improve fracture performance, i.e., the ability of the vascular occlusive device 110 to bend and fold to conform to the shape of a body cavity. These characteristics of the braided portion 120 make the vascular occlusive device 110 more suitable for intrasaccular embolization of vascular defects such as aneurysms, ie, substantially uniform visualization grayscale and optimal flexibility distribution throughout the vascular occlusive device 110 .

[0051] At least a portion of the vascular occlusive device 110 is braided with 16 to 32 DFT wires, each having a cross-sectional diameter of 0.00075 inches to 0.0015 inches, and a Pt content of 35% to 60%, which simultaneously provides improved radiopacity, shape retention, and fracture performance properties. As the Pt content increases, the effect of increasing the Pt content on reducing flexibility decreases. Therefore, a braid woven with DFT wires having a Pt content of 35% to 60% is unexpectedly suitable for vascular occlusive applications, such as intracapsular applications requiring a flexible device. Such braids are particularly suitable when they are woven with 24 to 32 DFT wires, each having a cross-sectional diameter of 0.00075 inches to 0.00125 inches. According to various aspects of the present disclosure, at least a portion of the vascular occlusive device 110 is braided with 24 to 32 DFT wires, each having a cross-sectional diameter of 0.00075 inches to 0.00125 inches, and a Pt content of 40% to 50%.

[0052] Typically, the austenite finish temperature or “A” of NiTi f The temperature is about 25°C, which is the temperature at which the martensite phase completes its transformation to the austenite phase. Modify NiTi in DFT so that its A f The temperature is between 30°C and 45°C, resulting in a softer vascular occlusive device. f The temperature setting in this range achieves an ideal balance between device flexibility and conformability, thereby improving the device's applicability for aneurysm treatment. The A of NiTi can be set by adjusting the Ni content in NiTi from the normal 50% to 50.4%-50.8%. f In addition, A can be adjusted by heat treating NiTi.f According to various aspects of the present disclosure, A f The temperature is between 38°C and 40°C.

[0053] DFT can also include an oxide coating of controlled thickness, which will enhance thrombosis (e.g., coagulation) to increase vascular occlusion within an aneurysm. Preferably, the average thickness of the oxide coating is between 50nm and 500nm. This is in contrast to previous DFT braided implants (e.g., stents), in which the oxide coating was substantially removed (e.g., via electropolishing) to produce a "bright" stent. In previous DFT braided stents, the oxide coating thickness was limited to less than 50nm.

[0054] In other embodiments, instead of DFT wires, the braided portion 120 can be braided by elongated members formed by twisting together smaller DFT wires. Each DFT wire can be made of Niti-DFT-40Pt. Braiding the elongated members (made of smaller DFT wires) instead of larger DFT wires makes the braided portion 120 softer with approximately the same Pt ​​core content. Therefore, the braided portion 120 (i.e., the twisted elongated member braid) according to this aspect of the present disclosure provides similar radiopacity with a softer braid. Such a braid also provides a larger surface area to promote thrombosis, thereby enhancing aneurysm occlusion.

[0055] The proximal and distal coiled portions 130, 140 are atraumatic coils to minimize tissue damage during insertion and deployment of the vaso-occlusive device 110. The proximal and distal coiled portions 130, 140 may be coils wound with one or more types of wires such as nitinol wire, DFT, or other alloy wires.

[0056] The vascular occlusion treatment system 100 includes a vascular occlusive device 110 coupled to a delivery assembly 150 via a delivery connector 160. The delivery assembly 150 includes an electrolytically degradable segment 152 at its distal end. The vascular occlusive device 110 includes a braided portion 120 coupled to a proximal coiled portion and a distal coiled portion 130, 140 via a proximal device internal connector and a distal device internal connector 170, 180, respectively. The braided portion 120 is braided from an alloy wire or other wire (e.g., DFT) as described above, and has a substantially constant width (i.e., cross-sectional dimension). The proximal coiled portion and the distal coiled portion 130, 140 are respective coils wound from one or more alloy wires (e.g., DFT wire) as described above. According to various aspects of the present disclosure, the braided portion and the proximal coiled portion and the distal coiled portion 120, 130, 140 can be formed from any elongated member. The proximal coiled portion 130 also has a proximal stretch-resistant member 132, which extends distally from the delivery connector 160, passes through the proximal coiled portion 130, reaches the proximal device internal connector 170, and reduces the stretching of the proximal coiled portion 130 when the proximal coiled portion 130 is pulled proximally during delivery.

[0057] like Figure 2A and Figure 2B As shown, the proximal stretch-resistant member 132 is made of two braided wires. Figure 2A A first step in manufacturing the braided portion 120 is shown. During manufacturing, a necked portion of the braided portion 120 is compressed using a tie line 210 to form a bundle 220. Figure 2B The second step of manufacturing the braided portion 120 is shown, in which all but two of the braided wires are trimmed. The remaining two untrimmed braided wires are then used to form the proximal stretch-resistant member 132.

[0058] The delivery connector 160 includes a link / adapter 162 that couples to both the distal end of the delivery assembly 150 and the open proximal end of the proximal coiled portion 130, thereby coupling the delivery assembly 150 and the proximal coiled portion 130. The link 162 can be formed of a sheet of material, as described in U.S. Pat. No. 8,202,292, which is incorporated herein by reference above. The link 162 is generally flat and includes a plurality of fingers 163 formed at its proximal end. The link also includes proximal and distal holes 164, 165. The proximal coiled portion 130 of the vaso-occlusive device 110 is a coil having open pitch proximal windings 134 at its open proximal end. At least some of these proximal windings 134 are interwoven with the fingers 163 of the link 162, coupling the link 162 to the proximal coiled portion 130 of the vaso-occlusive device 110.

[0059] As described above, the delivery connector 160 also includes a hook 154 formed by the distal end of the core wire of the delivery assembly 150. The hook 154 passes through the proximal hole 164 of the link 162 to couple the delivery assembly 150 and the link 162 (and the proximal coiled portion 130 coupled thereto). The proximal end of the proximal stretch-resistant member 132 terminates near the link 162 adjacent to the distal hole 165 of the link 162, thereby mechanically coupling the link 162 (and the delivery assembly 150 coupled thereto) to the proximal coiled portion 130 of the vascular occlusive device 110. The delivery connector 160 also includes a drop of adhesive 166 that penetrates through the open pitch proximal winding 134 to the proximal end of the vascular occlusive device 110 and bonds together: (1) the hook 154 of the delivery assembly 150; (2) the link 162; (3) the proximal end of the proximal stretch-resistant member 132; and (4) the open proximal end of the proximal coiled portion 130 of the vascular occlusive device 110, thereby forming the delivery connector 160.

[0060] The proximal device interjoint 170 includes a distal end of the proximal coiled portion 130 of the vaso-occlusive device 110 and a necked proximal end of the braided portion 120 of the vaso-occlusive device 110. The proximal end of the braided portion 120 is necked so that it fits inside the open distal end of the proximal coiled portion 130. The proximal device interjoint 170 also includes an adhesive drop 176 that penetrates the coiled open distal end of the proximal coiled portion 130 of the vaso-occlusive device 110. The adhesive 176 bonds together: (1) the open distal end of the proximal coiled portion 130 of the vaso-occlusive device 110; (2) the distal end of the proximal stretch-resistant member 132; and (3) the proximal end of the braided portion 120 of the vaso-occlusive device 110, thereby forming the proximal device interjoint 170.

[0061] The distal device internal joint 180 is a mirror image of the proximal device internal joint 170. The distal device internal joint 180 includes a necked distal end of the braided portion 120 of the vaso-occlusive device 110 and an open proximal end of the distal coiled portion 140 of the vaso-occlusive device 110. The distal end of the braided portion 120 is necked so that it fits inside the open proximal end of the distal coiled portion 140. The distal device internal joint 180 also includes an adhesive drop 186 that penetrates the coiled open proximal end of the distal coiled portion 140 of the vaso-occlusive device 110. The adhesive 186 bonds together: (1) the distal end of the braided portion 120 of the vaso-occlusive device 110; (2) the proximal end of the distal stretch-resistant member 142; and (3) the open proximal end of the distal coiled portion 140 of the vaso-occlusive device 110, thereby forming the distal device internal joint 180.

[0062] The distal coiled portion 140 also has an atraumatic distal tip 144 that can be formed by a small amount of adhesive. The distal end of the distal stretch-resistant member 142 extends from the distal device inner joint 180, through the distal coiled portion 140, and to the atraumatic distal tip 144, wherein the distal end of the distal stretch-resistant member 142 terminates within the atraumatic distal tip 144.

[0063] Figure 3 A vascular occlusion treatment system 300 is depicted in accordance with various aspects of the present disclosure. The vascular occlusion treatment system 300 and Figure 1 300. The primary difference between the vascular occlusion treatment systems 100 and 300 is that the proximal and distal stretch-resistant members 332, 342 in the vascular occlusion treatment system 300 are external stretch-resistant members rather than extensions from the braided wires of the braided portion 320. The external stretch-resistant members may be selected to have physical properties (e.g., diameter, strength, flexibility, etc.) that are independent of the braided wires in the braided portion 320. Thus, the external stretch-resistant members may be selected to adjust the physical properties of the various portions of the vascular occlusion treatment system 300 (e.g., the delivery connector 360, the proximal coiled portion 330, the proximal device intra-connector 370, the distal device intra-connector 380, and the distal coiled portion 340) independently of the braided wires in the braided portion 320.

[0064] The vascular occlusive treatment system 300 includes a vascular occlusive device 310, which is connected to a delivery assembly 350 via a delivery connector 360. The delivery assembly 350 includes an electrolytically degradable segment 352 at its distal end. The vascular occlusive device 310 includes a braided portion 320 connected to a proximal coiled portion and a distal coiled portion 330, 340 via a proximal device internal connector and a distal device internal connector 370, 380, respectively. The braided portion 320 can be braided from a DFT (i.e., composite) wire or other alloy wire as described above, and has a substantially constant width (i.e., cross-sectional size). The proximal coiled portion and the distal coiled portion 330, 340 are coils wound from one or more DFT wires or other alloy wires as described above, respectively. According to various aspects of the present disclosure, the braided portion and the proximal coiled portion and the distal coiled portion 320, 330, 340 can be formed from other elongated members. The proximal coiled portion 330 also has a proximal stretch-resistant member 332, which extends distally from the delivery connector 360, passes through the proximal coiled portion 330, extends to the proximal device inner connector 370, and reduces the stretching of the proximal coiled portion 330 when the proximal coiled portion 330 of the vascular occluding device 310 is pulled proximally during delivery.

[0065] The proximal stretch-resistant member 332 is an external stretch-resistant member that can be made of a DFT (ie, composite) wire or other elongated member. The proximal stretch-resistant member 332 has a first end and a second end 333, 335 and a bend 336 between the first end and the second end 333, 335.

[0066] The delivery connector 360 includes a link / adapter 362 coupled to the distal end of the delivery assembly 350 and the open proximal end of the proximal coiled portion 330, thereby coupling the delivery assembly 350 and the proximal coiled portion 330. The link 362 can be formed of a sheet material, as described in U.S. Pat. No. 8,202,292, which is incorporated herein by reference above. The link 362 is generally flat and includes a plurality of fingers 363 formed in its proximal end. The link also includes proximal and distal holes 364, 365. The proximal coiled portion 330 of the vaso-occlusive device 310 is a coil having open pitch proximal windings 334 at its open proximal end. At least some of these proximal windings 334 are interwoven with the fingers 363 of the link 362, thereby coupling the link 362 to the proximal coiled portion 330 of the vaso-occlusive device 310.

[0067] As described above, the delivery connector 360 also includes a hook 354 formed by the distal end of the core wire of the delivery assembly 350. The hook 354 passes through the proximal hole 364 of the link 362, thereby coupling the delivery assembly 350 and the link 362 (and the proximal coiled portion 330 coupled thereto). The first and second ends 333, 335 of the proximal stretch-resistant member 332 terminate near the link 362 adjacent to the distal hole 365 of the link 362, thereby mechanically coupling the link 362 (and the delivery assembly 350 coupled thereto) to the proximal coiled portion 330 of the vaso-occlusive device 310. The delivery connector 360 also includes a drop of adhesive 366 that penetrates through the open pitch proximal winding 334 to the proximal end of the vascular occlusive device 310 and bonds together: (1) the hook 354 of the delivery assembly 350; (2) the link 362; (3) the first and second ends 333, 335 of the proximal stretch-resistant member 332; and (4) the open proximal end of the proximal coiled portion 330 of the vascular occlusive device 310, thereby forming the delivery connector 360.

[0068] The proximal device inter-joint 370 includes the distal end of the proximal coiled portion 330 of the vaso-occlusive device 310 and the necked proximal end of the braided portion 320 of the vaso-occlusive device 310. The proximal end of the braided portion 320 is necked to form a constricted proximal end bundle 372 that fits inside the open distal end of the proximal coiled portion 330. The curved portion 336 of the proximal stretch-resistant member 332 wraps around the proximal constricted end bundle 372 and passes through the opening in the proximal end of the braided portion 320, thereby mechanically securing the proximal stretch-resistant member 332 to the braided portion 320 of the vaso-occlusive device 310. The proximal device inter-joint 370 also includes an adhesive drop 376 that penetrates the coiled open distal end of the proximal coiled portion 330 of the vaso-occlusive device 310. The adhesive 376 bonds together: (1) the open distal end of the proximal coiled portion 330 of the vaso-occlusive device 310; (2) the bend 336 of the proximal stretch-resistant member 332 surrounding the constricted proximal end bundle 372; and (3) the constricted proximal end bundle 372 of the braided portion 320, thereby forming a proximal device internal joint 370.

[0069] Similar to the proximal stretch-resistant member 332, the distal stretch-resistant member 342 is an external stretch-resistant member that can be made of a DFT (i.e., composite) wire or other elongated member. The distal stretch-resistant member 342 has a first end and a second end 343, 345 and a bend 346 between the first end and the second end 343, 345.

[0070] The distal device internal joint 380 is a mirror image of the proximal device internal joint 370. The distal device internal joint 380 includes a necked distal end of the braided portion 320 of the vaso-occlusive device 310 and an open proximal end of the distal coiled portion 340 of the vaso-occlusive device 310. The distal end of the braided portion 320 is necked to form a constricted distal end bundle 382 that fits inside the open proximal end of the distal coiled portion 340. The curved portion 346 of the distal stretch-resistant member 342 wraps around the distal constricted end bundle 382 and passes through the opening in the distal end of the braided portion 320, thereby mechanically securing the distal stretch-resistant member 342 to the braided portion 320 of the vaso-occlusive device 310. The distal device internal joint 380 also includes an adhesive drop 386 that penetrates the coiled open proximal end of the distal coiled portion 340 of the vaso-occlusive device 310. The adhesive 376 bonds together: (1) the constricted distal end bundle 382 of the braided portion 320; (2) the curved portion 346 of the distal stretch-resistant member 342 surrounding the constricted distal end bundle 382; and (3) the open proximal end of the distal coiled portion 340 of the vascular occluding device 310, thereby forming a distal device internal joint 380.

[0071] The distal coiled portion 340 also has an atraumatic distal tip 344, which can be formed by a small amount of adhesive. The first and second ends 343, 345 of the distal stretch-resistant member 342 extend from the distal device inner joint 380, through the distal coiled portion 340, and extend to the atraumatic distal tip 344, wherein the first and second ends 343, 345 of the distal stretch-resistant member 342 terminate within the atraumatic distal tip 344.

[0072] Figure 4 A vascular occlusion treatment system 400 is depicted in accordance with various aspects of the present disclosure. The vascular occlusion treatment system 400 and Figure 3 400, and similar elements have similar reference numbers. The primary difference between the vascular occlusion treatment systems 300 and 400 is that the second end 445 of the distal stretch-resistant member 442 in the vascular occlusion treatment system 400 terminates in the middle of the distal coiled portion 440, rather than extending all the way to the atraumatic distal tip 444 at the distal end of the distal coiled portion 440.

[0073] Figure 5 A vascular occlusion treatment system 500 is depicted in accordance with various aspects of the present disclosure. The vascular occlusion treatment system 500 and Figure 3 The vascular occlusion treatment system 300 is similar to that depicted in FIG. 1 , and similar elements have similar reference numbers. Figure 3 As with the delivery connector 360 in the embodiment of the present invention, as described above, the delivery connector 560 includes a hook 554 formed by the distal end of the core wire of the delivery assembly 550. The hook 554 passes through the proximal hole 564 of the link 562, thereby coupling the delivery assembly 550 to the link 562 (and the proximal coiled portion 530 coupled thereto). One difference between the vascular occlusion treatment systems 300 and 500 is that the proximal stretch-resistant member 532 passes through the proximal hole 565 of the link 562, so that the curved portion 536 in the proximal stretch-resistant member 532 is disposed in the proximal hole 565, thereby mechanically coupling the link 562 (and the delivery assembly 550 coupled thereto) to the proximal coiled portion 530 of the vascular occlusion device 510. The delivery connector 560 also includes a drop of adhesive 566 that penetrates through the open pitch proximal winding 534 to the proximal end of the vascular occluding device 510 and bonds together: (1) the hook 554 of the delivery assembly 550; (2) the link 562; (3) the bend 536 of the proximal stretch-resistant member 532; and (4) the open proximal end of the proximal coiled portion 530 of the vascular occluding device 510, thereby forming the delivery connector 560.

[0074] The proximal device inter-joint 570 includes the distal end of the proximal coiled portion 530 of the vaso-occlusive device 510 and the necked proximal end of the braided portion 520 of the vaso-occlusive device 510. The proximal end of the braided portion 520 is necked to form a constricted proximal end bundle 572 that fits inside the open distal end of the proximal coiled portion 530. Another difference between the vaso-occlusive treatment systems 300, 500 is that the first and second ends 533, 535 of the proximal stretch-resistant member 532 in the vaso-occlusive treatment system 500 each terminate proximal to (e.g., locked onto) the proximal end of the braided portion 520 at the distal end of the proximal constricted end bundle 572, rather than forming a bend 336 as in the vaso-occlusive treatment system 300. The proximal device inter-joint 570 also includes an adhesive drop 576 that penetrates the coiled open distal end of the proximal coiled portion 530 of the vaso-occlusive device 510. The adhesive 576 bonds together: (1) the open distal end of the proximal coiled portion 530 of the vascular occlusive device 510; (2) the first and second ends 533, 535 of the proximal stretch-resistant member 532 of the constricted proximal end bundle 572 surrounding the braided portion 520; and (3) the constricted proximal end bundle 572, thereby forming a proximal device internal joint 570.

[0075] Similar to the proximal stretch-resistant member 532, the distal stretch-resistant member 542 is an external stretch-resistant member that can be made of a DFT (i.e., composite) wire or other elongated member. The distal stretch-resistant member 542 has a first end and a second end 543, 545 and a bend 546 between the first end and the second end 543, 545.

[0076] The distal device internal joint 580 is a mirror image of the proximal device internal joint 570. The distal device internal joint 580 includes a necked distal end of the braided portion 520 of the vaso-occlusive device 510 and an open proximal end of the distal coiled portion 540 of the vaso-occlusive device 510. The distal end of the braided portion 520 is necked to form a constricted distal end bundle 582 that fits inside the open proximal end of the distal coiled portion 540. The first and second ends 543, 545 of the distal stretch-resistant member 542 in the vaso-occlusive treatment system 500 each terminate proximal to (e.g., locked onto) the distal end of the braided portion 520 at the proximal end of the distal constricted end bundle 582, thereby mechanically securing the distal stretch-resistant member 542 to the braided portion 520 of the vaso-occlusive device 510. The distal device joint 580 also includes an adhesive drop 586 that penetrates the coiled open proximal end of the distal coiled portion 540 of the vaso-occlusive device 510. The adhesive 586 bonds together: (1) the constricted distal end bundle 582 of the braided portion 520; (2) the first and second ends 543, 545 of the distal stretch-resistant member 542 surrounding the constricted distal end bundle 582; and (3) the open proximal end of the distal coiled portion 540 of the vaso-occlusive device 510, thereby forming the distal device joint 580.

[0077] The distal coiled portion 540 also has an atraumatic distal tip 544, which can be formed by a small amount of adhesive. The distal stretch-resistant member 542 extends from the distal device internal joint 580, passes through the distal coiled portion 540, and extends to the atraumatic distal tip 544, wherein the bend 546 in the distal stretch-resistant member 542 is disposed in the atraumatic distal tip 544 at the distal end of the distal coiled portion 540.

[0078] Figure 6 A vascular occlusion treatment system 600 is depicted in accordance with various aspects of the present disclosure. The vascular occlusion treatment system 600 and Figure 5 600 and similar elements have similar reference numbers. The main difference between the vascular occlusion treatment systems 500 and 600 is that the second end 645 of the distal stretch-resistant member 642 in the vascular occlusion treatment system 600 terminates in the middle of the distal coiled portion 640, rather than extending all the way to the proximal end of the braided portion 620.

[0079] Figure 7 A vascular occlusion treatment system 700 is depicted in accordance with various aspects of the present disclosure. The vascular occlusion treatment system 700 and Figure 3700, and similar elements have similar reference numbers. The primary difference between the vascular occlusive treatment systems 300 and 700 is that the first and second ends 743, 745 of the distal stretch-resistant member 742 in the vascular occlusive treatment system 700 each terminate near (e.g., are locked onto) the distal end of the braided portion 720 proximal to the distal constricted end bundle 782. In addition, the bend 746 in the distal stretch-resistant member 742 is disposed in the atraumatic distal tip 744 at the distal end of the distal coiled portion 740.

[0080] Figure 8 Portions of a vascular occlusion treatment system 800 are depicted in accordance with various aspects of the present disclosure. Figure 8 Focus is placed on the proximal device internal joint 870 and the various components included therein (e.g., the proximal coiled portion 830, the proximal stretch-resistant member 832, the braided portion 820, the constricted proximal end bundle 872, and the adhesive 876). Figure 5 and Figure 6 For example, the first and second ends 833, 835 of the proximal stretch-resistant member 832 in the vascular occlusion treatment system 800 each terminate adjacent to (e.g., locked to) the proximal end of the braided portion 820 at the distal end of the proximal constricted end bundle 872. Each of the first and second ends 833, 835 terminate adjacent to (e.g., locked to) the proximal end of the braided portion 820 by passing through the braided portion 820 and then bending back toward itself.

[0081] Fig. 9 Portions of a vascular occlusion treatment system 900 are depicted in accordance with various aspects of the present disclosure. Fig. 9 Focus is placed on the proximal device internal joint 970 and the various components included therein (e.g., the proximal coiled portion 930, the proximal stretch-resistant member 932, the braided portion 920, the constricted proximal end bundle 972, and the adhesive 976). Figure 8 The main difference between the proximal device internal joints 870 and 970 is that the first and second ends 933 and 935 of the proximal stretch-resistant member 932 in the vascular occlusion treatment system 900 are respectively flattened on the braided portion 920 to form a proximal constricted end bundle 972 to connect the proximal stretch-resistant member 932 to the braided portion 920.

[0082] Fig.10 Portions of a vascular occlusion treatment system 1000 are depicted in accordance with various aspects of the present disclosure. Fig.10Focus is placed on the proximal device internal joint 1070 and the various components included therein (e.g., the proximal coiled portion 1030, the proximal stretch-resistant member 1032, the braided portion 1020, the constricted proximal end bundle 1072, and the adhesive 1076). Figure 8 The main difference between the proximal device internal joints 870 and 1070 is that the first and second ends 1033 and 1035 of the proximal stretch-resistant member 1032 in the vascular occlusion treatment system 1000 each terminate near the proximal end of the braided portion 1020 (e.g., locked thereto) by passing through the braided portion 1020 and then crossing with the other end to connect the proximal stretch-resistant member 1032 to the braided portion 1020.

[0083] FIG. 11A to FIG. 1 11 schematically depicts a method of manufacturing a vascular occlusive treatment system, the vascular occlusive treatment system including a vascular occlusive device, such as Figure 3 A vascular occlusive treatment system 300 and a vascular occlusive device 310 are depicted in FIG. Fig.11A Step 1110 is depicted in which the braided portion 320 is cut to length after secondary wrapping. Fig. 11B Step 1120 is depicted in which a heat shrink polymer tube 11 is disposed around the proximal end of the braided portion 320 and heat is applied to the heat shrink polymer tube 11 to compress the proximal end of the braided portion 320. An example of such a heat shrink polymer tube 11 is a PTFE heat shrink tube. Fig. 11C Step 1130 is depicted in which adhesive is applied to the proximal end of the compressed braided portion 320. For example, adhesive may be applied from the proximal end of the compressed braided portion 320 into the heat shrink polymer tube 11 along a desired length "L". Fig.11D Step 1140 is depicted in which a shrunk polymer tube (not shown) is removed from around the compressed proximal end of the braided portion 320 to form the proximal constricted braided end bundle 372 . Fig.11E Step 1150 is depicted in which the outer stretch resistant member 332 is passed through the distal end of the braided portion 320 at the proximal end of the constricted end bundle 372 to form a bend 336 passing through the proximal end of the braided portion 320 at the distal end of the constricted end bundle 372 . Fig.11F Step 1160 is depicted in which the first end 333 and the second end 335 of the outer stretch resistant member 332 are threaded into the proximal coiled portion 330 along with at least a portion of the proximal end of the proximal constricting braided end bundle 372 . Fig.11GStep 1170 is depicted in which adhesive 376 is applied to the distal end of the proximal coiled portion 330, the proximal constricted braided end bundle 372, the bend 336 in the outer stretch resistant member 332, and the proximal end of the braided portion 320 to form the proximal device internal joint 370. Fig.11H Step 1180 is depicted, in which the first and second ends 333, 335 of the outer stretch-resistant member 332 are coupled to the link 362 connected to the delivery wire assembly 350, and the proximal end 334 of the proximal coiled portion 330 is threaded onto the finger 363 of the link 362. Adhesive 366 is then applied to the distal end of the delivery assembly 350, the link 362, the proximal end of the proximal coiled portion 330, and the first and second ends 333, 335 of the outer stretch-resistant member 332 to complete the assembly of the delivery connector 360. FIG. 111 depicts step 1190, in which steps 11B to 11G are repeated for the distal end of the braided portion 320, and adhesive is applied to the distal end of the distal coiled portion 340 to secure the first and second ends 343, 345 of the distal outer stretch-resistant member 342 to complete the assembly of the vaso-occlusive treatment system 300 and the vaso-occlusive device 310.

[0084] FIG. 12A to FIG. 12I A method of manufacturing a vascular occlusive treatment system comprising a vascular occlusive device, such as Figure 5 A vascular occlusive treatment system 500 and a vascular occlusive device 510 are depicted in FIG. Fig. 12A Step 1210 is depicted in which the braided portion 520 is cut to length after secondary wrapping. Fig. 12B Step 1220 is depicted in which a heat shrink polymer tube 11 is disposed around the proximal end of the braided portion 520 and heat is applied to the heat shrink polymer tube 11 to compress the proximal end of the braided portion 520. An example of the heat shrink polymer tube 11 is a PTFE heat shrink tube. Fig. 12C Step 1230 is depicted in which adhesive is applied to the proximal end of the compressed braided portion 520. For example, adhesive may be applied from the proximal end of the compressed braided portion 520 into the heat shrink polymer tube 11 along a desired length "L". Fig.12D Step 1240 is depicted in which the outer stretch-resistant member 532 is passed through the proximal aperture 565 of a link 562 connected to the delivery wire assembly 550 and the proximal end of the proximal coiled portion 530 is threaded onto the finger 563 of the link 562 . Fig.12E Step 1250 is depicted in which a shrunk polymer tube (not shown) is removed from around the compressed proximal end of the braided portion 520 to form the proximal constricted braided end bundle 572 . Fig.12F Step 1260 is depicted in which the proximal end of the proximal tightened braided end bundle 572 is inserted into the distal end of the proximal coiled portion 530 while maintaining the first and second ends 533, 535 of the external stretch-resistant member 532 between the outer / external surface 572' of the proximal tightened braided end bundle 572 and the inner / inner surface 530' of the distal end of the proximal coiled portion 530. Figure 12G Step 1270 is depicted in which the first and second ends 533, 535 of the outer stretch-resistant member 532 are terminated adjacent to (e.g., locked onto) the proximal end of the braided portion 520 and are trimmed. Each of the first and second ends 533, 535 terminates adjacent to (e.g., locked onto) the proximal end of the braided portion 520 by passing through the braided portion 520 and then bending toward itself. Fig.12H Step 1280 is depicted in which adhesive 576 is applied to the distal end of the proximal coiled portion 530, the proximal constricted braided end bundle 572, the first and second ends 533, 535 of the external stretch-resistant member 532, and the proximal end of the braided portion 520 to form a proximal device internal joint 570. Fig.12I Step 1290 is depicted, in which steps 12B to 12G are repeated on the distal end of the braided portion 520 to form the distal device internal joint 580, and adhesive is applied to the distal end of the distal coiled portion 540 to secure the bend 546 in the distal external stretch-resistant member 542, thereby completing the assembly of the vascular occlusion treatment system 500 and the vascular occlusive device 510.

[0085] FIG. 13A to FIG. 13D A proximal constriction braided end bundle is depicted in accordance with various aspects of the present disclosure. Fig.13A Depicted is a proximal constricted braid end bundle 1372 formed by the compressed proximal end of the braided portion 1320 and the adhesive 13, such as described herein. Fig. 13B A proximal constricted braided end bundle 1372 is depicted, which is secured in place by heat shrink tubing 11 around the compressed proximal end of the braided portion 1320 without the addition of adhesive / glue. The proximal end of the proximal constricted end bundle 1372 has a surface 1302 that is generally orthogonal to the longitudinal axis 1301 of the braided portion 1320. Fig. 13C Also depicted is a proximal constricted braided end bundle 1372 having a proximal surface 1303 that is inclined or angled relative to the longitudinal axis 1301 of the braided portion 1320. Such an inclined surface 1303 facilitates insertion of the proximal constricted end bundle 1372 into the coiled portion. Fig.13DA proximal constricted end bundle 1372 formed by the compression and welding of the proximal ends of the braided portion 1320 is depicted.

[0086] The external stretch-resistant member can have any shape and any form. For example, the external stretch-resistant member can be a wire or tube with various cross-sectional shapes. The external stretch-resistant member can be made of any type of biocompatible material. The external stretch-resistant member can be made of the same material as the braided wire or a different material. For example, it can be a DFT having a composition as described above. The external stretch-resistant member can also be made of metals or alloys, such as platinum (Pt), tungsten (W), gold (Au), platinum group metals and their alloys. For example, the external stretch-resistant member can be made of Pt-8%wtW (Pt-8W) or Au-34%wtPt (AuPt34). The delivery joint manufactured using the external stretch-resistant member described herein can have an improved joint tensile strength. According to various aspects of the present disclosure, an external stretch-resistant member made of AuPt34 with a diameter of 0.0011 inches is incorporated into a delivery joint such as described herein, so that the tensile strength of the delivery joint reaches 0.350 pounds ± 0.025 pounds. Incorporating external stretch-resistant members such as those described herein into vaso-occlusive devices and vaso-occlusive treatment systems may also simplify assembly, particularly of connectors within the devices, and may allow the tensile strength of the delivery connector to be controlled independently of braid properties or braid diameter.

[0087] Various aspects of the present disclosure will be described below with reference to the accompanying drawings. It should be noted that the drawings are not drawn to scale and that elements of similar structure or function are represented by the same reference numerals in all drawings. It should also be noted that the drawings are only used for convenience of description and are not intended to be an exhaustive description of the present disclosure or a limitation on the scope of the present disclosure, which is defined only by the attached claims and their equivalents. In addition, the various aspects shown do not necessarily have all the features or advantages of the aspects described herein. Features or advantages described in conjunction with a particular aspect of the present disclosure are not necessarily limited to that aspect and may be practiced by any other aspect even if not shown.

Claims

1. A system for treating vascular occlusion, include: Conveying components; as well as A vascular occlusive device removably coupled to the delivery assembly via a delivery assembly connector, the vascular occlusive device comprising: a braided portion formed from one or more threads, said braided portion comprising a constricted end bundle, a coiled portion coupled to the braided portion; as well as An in-device joint couples the braided portion to the coiled portion, the in-device joint comprising a stretch-resistant member spanning from the constricted end bundle to the delivery assembly joint.

2. The vascular occlusion treatment system according to claim 1, in, The constricted end bundle includes an adhesive disposed at an end of the braided portion.

3. The vascular occlusion treatment system according to any one of claims 1, in, The constricted end bundle includes a weld provided at an end of the braided portion.

4. The vascular occlusion treatment system according to any one of claims 1 to 3, in, The constricted end bundle defines an end surface that is orthogonal to a longitudinal axis of the constricted end bundle.

5. The vascular occlusion treatment system according to any one of claims 1 to 3, in, The constricted end bundle defines an end surface that is inclined relative to a longitudinal axis of the constricted end bundle.

6. The vascular occlusion treatment system according to any one of claims 1 to 5, in, The stretch resistant member includes a first end and a second end.

7. The vascular occlusion treatment system according to claim 6, in, The first end of the stretch resistant member terminates in the transmission line connector, and The second end of the stretch-resistant member is terminated in the braided portion or the coiled portion.

8. The vascular occlusion treatment system according to claim 6 or 7, in, The first end and the second end are flat.

9. The vascular occlusion treatment system according to claim 6, in, The first end and the second end each terminate within the braided portion.

10. The vascular occlusion treatment system according to claim 6, in, The first end portion and the second end portion cross each other within the braided portion.

11. The vascular occlusion treatment system according to claim 6, in, The stretch resistant member also includes a bend.

12. The vascular occlusion treatment system according to claim 11, in, The first end and the second end terminate in the transmission line connector, and Wherein, the curved portion is arranged near the constricted end bundle.

13. The vascular occlusion treatment system according to claim 12, in, The bend is disposed at a distal end of the constricted end bundle.

14. The vascular occlusion treatment system according to claim 11, in, The first and second ends terminate adjacent the constricted end bundle, and Wherein, the bending portion is arranged in the transmission line joint.

15. The vascular occlusion treatment system according to claim 14, in, The delivery assembly connector includes a link defining an opening, and Wherein, the bent portion is arranged in the opening.

16. The vascular occlusion treatment system according to claim 14 or 15, in, Each of the first end and the second end terminates within the braided portion.

17. The vascular occlusion treatment system of claim 6, further comprising a second stretch-resistant member, in, The second stretch resistant member includes a third end and a fourth end.

18. The vascular occlusion treatment system according to claim 17, in, The first end and the third end terminate in the transmission line connector, and Wherein, the second end and the fourth end terminate near the constricted end bundle.

19. The vascular occlusion treatment system according to any one of claims 1 to 5, in, The stretch resistant member is a ring including a first bend and a second bend.

20. The vascular occlusion treatment system according to claim 19, in, The first bend is disposed within the transmission line connector, and Wherein, the second curved portion is arranged near the constricted end bundle.

21. The vascular occlusion treatment system according to claim 20, in, The first bend is disposed at a distal end of the constricted end bundle.

22. The vascular occlusion treatment system according to claim 20 or 21, in, The delivery assembly connector includes a link defining an opening, and Wherein, the second curved portion is arranged in the opening.

23. A vascular occlusion treatment system according to any one of claims 1 to 44, in, The constricted end bundle is a proximal end bundle, wherein the coiled portion is a proximal coiled portion, Wherein, the device internal joint is a proximal device internal joint, wherein the anti-stretching member is a proximal anti-stretching member, Wherein, the braided portion further comprises a distal tightening end bundle, Wherein, the system further comprises: a distal coiled portion coupled to the distal constricted end bundle; A distal device inter-joint couples the braided portion to the distal coiled portion, the distal device inter-joint comprising a distal stretch-resistant member spanning from the distal constricted end bundle to a distal end of the distal coiled portion.

24. The vascular occlusion treatment system according to claim 23, in, The distal constricted end bundle includes an adhesive disposed at a distal end of the braided portion.

25. The vascular occlusion treatment system according to any one of claims 23, in, The distal constricted end bundle includes a weld disposed at a distal end of the braided portion.

26. A vascular occlusion treatment system according to any one of claims 23 to 25, in, The distal constricted tip bundle defines a distal end surface that is orthogonal to a longitudinal axis of the distal constricted tip bundle.

27. A vascular occlusion treatment system according to any one of claims 23 to 25, in, The distal constricted tip bundle defines a distal end surface that is inclined relative to a longitudinal axis of the distal constricted tip bundle.

28. A vascular occlusion treatment system according to any one of claims 23 to 27, in, The distal stretch-resistant member includes a first distal stretch-resistant member end and a second distal stretch-resistant member end.

29. The vascular occlusion treatment system according to claim 28, in, The first distal stretch-resistant member end of the distal stretch-resistant member terminates in a distal end of the distal coiled portion, and Wherein, the second distal stretch-resistant member end of the distal stretch-resistant member is terminated in the braided portion or the distal coiled portion.

30. The vascular occlusion treatment system according to claim 28 or 29, in, The first distal stretch-resistant member end and the second distal stretch-resistant member end are flat.

31. The vascular occlusion treatment system of claim 28, in, The first distal stretch-resistant member end and the second distal stretch-resistant member end each terminate within the braided portion.

32. The vascular occlusion treatment system of claim 28, in, The first distal stretch resistant member end and the second distal stretch resistant member end cross each other within the braided portion.

33. The vascular occlusion treatment system of claim 28, in, The distal stretch-resistant member further includes a distal stretch-resistant member bend.

34. The vascular occlusion treatment system of claim 33, in, The first distal stretch-resistant member end and the second distal stretch-resistant member end terminate within the distal end of the distal coiled portion, and Wherein, the distal anti-stretch member bending portion is arranged near the distal tightening end bundle.

35. The vascular occlusion treatment system of claim 34, in, The distal stretch-resistant member bend is disposed proximal to the distal constricted end bundle.

36. The vascular occlusion treatment system of claim 33, in, The first distal stretch-resistant member end and the second distal stretch-resistant member end terminate adjacent the distal constricted end bundle, and Wherein, the distal anti-stretch member bending portion is arranged in the distal end of the distal coiled portion.

37. The vascular occlusion treatment system of claim 36, in, Each of the first distal stretch-resistant member end and the second distal stretch-resistant member end terminates within the braided portion.

38. The vascular occlusion treatment system of claim 28, further comprising a second distal stretch-resistant member, in, The second distal stretch-resistant member includes a third distal stretch-resistant member end and a fourth distal stretch-resistant member end.

39. The vascular occlusion treatment system of claim 38, in, The first distal stretch-resistant member end and the third distal stretch-resistant member end terminate within the distal end of the distal coiled portion, and Wherein, the second distal stretch-resistant member end and the fourth distal stretch-resistant member end terminate near the distal constricted end bundle.

40. A vascular occlusion treatment system according to any one of claims 23 to 27, in, The distal stretch-resistant member is a ring including a first distal stretch-resistant member bend and a second distal stretch-resistant member bend.

41. The vascular occlusion treatment system of claim 40, in, The first distal stretch resistant member bend is disposed within the distal end of the distal coiled portion, and Wherein, the second distal anti-stretch member bending portion is arranged near the distal constricted end bundle.

42. The vascular occlusion treatment system of claim 41, in, The first distal stretch-resistant member bend is disposed proximal to the distal constricted end bundle.

43. The vascular occlusion treatment system of any one of claims 1 to 42, wherein the delivery assembly has a distal end, in, The distal end forms a hook.

44. The vascular occlusion treatment system of any one of claims 1 to 43, wherein the delivery assembly connector comprises a link having a proximal end and a distal end, in, The distal end of the link includes a plurality of fingers.

45. A method of manufacturing a vascular occlusion treatment system, include: forming a vascular occlusive device, wherein forming the vascular occlusive device comprises: providing a tube around a proximal end of a braided portion formed of one or more wires, applying heat to the tube to shrink the tube around the proximal end of the braided portion to form a shrunken proximal end, Apply glue to the proximal end of the constriction to form a constricted end bundle, Remove the tube from around the constricted end bundle, Passing a stretch-resistant member through a braided portion adjacent to a distal end of the constricted end bundle to form a curved portion of the stretch-resistant member in the braided portion adjacent to the distal end of the constricted end bundle, inserting at least a portion of the constricted end bundle and the stretch resistant member into the coiled portion, applying glue to the constricted end bundle and the curved portion of the stretch resistant member to form an in-device joint; connecting a distal end of a delivery assembly to a proximal end of the coiled portion and a proximal end of the stretch-resistant member; Glue is applied to the distal end of the delivery assembly, the proximal end of the coiled portion, and the proximal end of the stretch-resistant member to form a delivery joint.

46. ​​The method according to claim 45, in, The coiled portion is a proximal coiled portion, The method also includes coupling a distal coiled portion to a distal end of the braided portion.

47. A method of manufacturing a vascular occlusion treatment system, include: Forming a compact end bundle, wherein forming the compact end bundle comprises: providing a tube around a proximal end of a braided portion formed of one or more wires, applying heat to the tube to shrink the tube around the proximal end of the braided portion to form a shrunken proximal end, Apply glue to the proximal end of the constriction to form a constricted end bundle, removing the tube from around the constricted end bundle; Forming a transport joint, wherein forming the transport joint comprises: coupling the distal end of the link to the proximal end of the coiled portion, coupling the distal end of the delivery assembly to the proximal end of the link, passing a stretch resistant member through an opening defined by the link to form a bend of the stretch resistant member in the opening, applying glue to the link, the proximal end of the coiled portion, the distal end of the delivery assembly, and the curved portion of the stretch-resistant member to form the delivery joint; inserting at least a portion of the constricted end bundle into the coiled portion; coupling an end of the stretch resistant member to the braided portion adjacent a distal end of the constricted end bundle; Glue is applied to the constricted end bundles and the ends of the stretch resistant members to form an intra-device joint.

48. The method according to claim 47, in, The coiled portion is a proximal coiled portion, The method also includes coupling a distal coiled portion to a distal end of the braided portion.